AbbVie AG - Lumigan, 0.1 mg/ml, Augentropfen | | 55918 | | 02 | | Lumigan, 0.1 mg/ml | | Augentropfen | | S01EE03 | | Bimatoprost | | 09.02.2010 | | |
| Composition | bimatoprostum 0.1 mg, benzalkonii chloridum 200 µg, dinatrii phosphas heptahydricus corresp. phosphas 0.95 mg, acidum citricum monohydricum, natrii chloridum, acidum hydrochloridum aut natrii hydroxidum ad pH, aqua purificata, ad solutionem pro 1 ml. | Packungsbestandteile | | Collyre | | | | | | Principe actif | Concentr. |
---|
Bimatoprost | 0.1 mg/ml |
| BAG: Principe actif | Concentr. |
---|
Bimatoprost | 0.1 mg |
| | Agents auxilliaires | Concentr. |
---|
Acide Citrique Monohydre | | Acidum Hydrochloridum aut Natrii Hydroxidum ad Ph | | Aqua Purificata | | Benzalkonium Chlorure | 200 µg/ml | Disodium Phosphate Heptahydrate | | Sodium Chlorure | |
| |
| |
|